BIMATOPROST

作品数:35被引量:24H指数:3
导出分析报告
相关领域:医药卫生更多>>
相关作者:李欣赵家良程金伟王涛邵慧更多>>
相关机构:北京协和医学院北京协和医院首都医科大学第二军医大学更多>>
相关期刊:《International Journal of Ophthalmology(English edition)》《Chinese Medical Journal》《Open Journal of Ophthalmology》《国际眼科杂志》更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
A Stability Indicating Reverse Phase-HPLC Method Development and Validation for the Estimation of Bimatoprost 0.3% &Timolol 0.5% Pharmaceutical Ophthalmic Dosage Form
《American Journal of Analytical Chemistry》2022年第12期506-530,共25页Md. S. Amin Muhammad T. Islam 
The research was carried out to establish a new reverse phase-HPLC stability indicating method for quantifying Bimatoprost & Timolol in ophthalmic solution. The experiment of Bimatoprost & Timolol in ophthalmic soluti...
关键词:BIMATOPROST TIMOLOL Reverse-Phase High Performance Liquid Chromatography Method Development Validation Stability Indicating 
Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients
《International Journal of Ophthalmology(English edition)》2017年第8期1251-1254,共4页Nicholas Brennan Mohammad H Dehabadi Sandhya Nair Aria Quartilho Catey Bunce Ian Reekie Raal Obikpo 
AIM: To establish the efficacy and safety of bimatoprost 0.03% monotherapy in glaucoma and ocular hypertension (OHT) patients with inadequate intraocular pressure (lOP) on current therapy. METHODS: Pre- and pos...
关键词:GLAUCOMA ocular hypertension BIMATOPROST LATANOPROST 
Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy
《International Journal of Ophthalmology(English edition)》2016年第5期750-756,共7页Ai-Wei Liu Lin-Yang Gan Xiang Yao Jian Zhou 
Supported by the National Outstanding Youth Science Fund Project(No.81202726)
AIM: To draw a Meta-analysis over the comparison of the intraocular pressure (lOP)-lowering efficacy and safety between the commonly used fixed-combinations of prostaglandin analogs and 0.5% timolol with prostaglan...
关键词:fixed combination of prostaglandin analogsand timolol latanoprost BIMATOPROST TAFLUPROST timolol open angle glaucoma ocular hypertension 
Bimatoprost/timolol fixed combination(BTFC) in patients with primary open angle glaucoma or ocular hypertension in Greece被引量:1
《International Journal of Ophthalmology(English edition)》2016年第1期69-75,共7页Tryfon G.Rotsos Vasso G.Kliafa Kevin J.Asher Dimitrios Papaconstantinou 
funded by Allergan,Inc.(Irvine,CA,USA)through Nexus Medicals S.A.,the exclusive distributor of Allergan products in Greece.Qualitis Ltd.,a contract research organization in Zografou,Greece,was responsible for data management in the study
AIM:To evaluate the efficacy and tolerability of the fixed combination of bimatoprost 0.03%and timolol 0.5%(BTFC)in patients in Greece with primary open angle glaucoma(POAG)or ocular hypertension(OHT)whose prev...
关键词:fixed combination GLAUCOMA INTRAOCULARPRESSURE ocular hypertension primary open angle glaucoma PROSTAGLANDIN prostamide TIMOLOL 
Ocular Surface Disease Index in Glaucomatous Patients Treated with Bimatoprost
《Open Journal of Ophthalmology》2014年第2期36-39,共4页Italo Giuffrè 
Objectives: To compare ocular surface changes induced via glaucoma treatment in patients using fixed combinations of bimatoprost 0.03%/timolol 0.50%, timolol 0.50% or bimatoprost 0.01% eye drops. Methods: This is a pr...
关键词:BIMATOPROST 0.01% BIMATOPROST 0.03%/Timolol 0.50% Fixed COMBINATION GLAUCOMA OSDI TIMOLOL 0.50% 
Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension
《Chinese Medical Journal》2014年第5期905-910,共6页Ling Zhihong Zhang Mingchang Hu Yizhen Yin Zhengqin Xing Yiqiao Fang Aiwu Ye Jian Chen Xiaoming Liu Dachuan Wang Yusheng Sun Wei Dong Yangceng Sun Xinghuai 
Background Lowering intraocular pressure (lOP) is currently the only therapeutic approach in primary open-angle glaucoma.and the fixed-combination medications are needed to achieve sufficiently low target lOP.A mult...
关键词:GLAUCOMA OPEN-ANGLE bimatoprost/timolol fixed combination BIMATOPROST 
Comparative Evaluation of the Efficacy of the Bimatoprost 0.03%, Brimonidine 0.2%, Brinzolamide 1%, Dorzolamide 2%, and Travoprost 0.004%/Timolol 0.5%-Fixed Combinations in Patients Affected by Open-Angle Glaucoma
《Open Journal of Ophthalmology》2012年第4期122-126,共5页Italo Giuffre 
Purpose: This is a retrospective, comparative, head-to-head, not commissioned study about the efficacy of bimato-prost 0.03%, brimonidine 0.2%, brinzolamide 1%, dorzolamide 2%, and travoprost 0.004%/timolol 0.5%-fixed...
关键词:BIMATOPROST 0.03% BRIMONIDINE 0.2% Brinzolamide 1% DORZOLAMIDE 2% TRAVOPROST 0.004%/Timolol 0.5% Fixed Combinations EFFICACY IOP 
0.03%Bimatoprost对正常无色素兔的降眼压机制研究被引量:1
《眼科研究》2007年第12期919-922,共4页李欣 赵家良 
目的研究前列腺素类似物的新成员—Bimatoprost的降眼压机制。方法将正常无色素兔双眼滴入0.03%Bimatoprost,按用药时间分为5组,应用酶谱分析法,检测滴用Bimatoprost不同时间后兔眼睫状肌匀浆上清液及房水中基质金属蛋白酶(MMPs)的变化...
关键词:青光眼 前列腺素类似物 基质金属蛋白酶 0.03%Bimatoprost 
0.03%Bimatoprost对正常无色素兔的降眼压作用及安全性研究被引量:2
《眼科研究》2007年第4期288-291,共4页李欣 赵家良 
目的研究前列腺素类似物的新成员Bimatoprost的降眼压作用,并评价其安全性。方法对正常无色素兔的一只眼滴入Bimatoprost,另一只眼滴入生理盐水,连续测量滴药前及滴药后的双眼眼压,绘制用药后眼压随时间变化曲线;并观察结膜充血情况及...
关键词:青光眼 眼压 前列腺素类似物 BIMATOPROST 
Bimatoprost引起眼部周围皮肤色素沉着组织病理学研究
《美国医学会眼科杂志(中文版)》2006年第4期210-215,共6页Rashmi Kapur Smajo Osmanovic Sami Toyran Deepak P. Edward 陆遥(译) 赵光喜(校) 
目的:研究卢美根引起眼部周围皮肤色素沉着的光镜和超微结构的改变。 方法:取使用卢美根后患者和对照患者的眼睑组织活检标本.进行光镜和透射电镜关。利用图形分析器。在Fontana-Masson-染色切片上计数黑色素颗粒。抗S100和CD3抗体...
关键词:皮肤色素沉着 组织病理学 周围 眼部 Bi 黑色素颗粒 黑色素细胞 活检标本 
检索报告 对象比较 聚类工具 使用帮助 返回顶部